WML Test Directory Toxicology Update (Correction) | July 2026

Announcement

This is a correction of the Toxicology 2026 update dated 6/26/2026. The corrected update now includes the inactivated tests that the new tests are replacing.

Update Summary

Effective Date	Update Type	Name
07/28/2026	New Test	PN04C – “Drug Screen, Pain Management Panel 4”	Jump to update
08/25/2026	Inactivated/Replace Test	PETCB – “Phosphatidylethanol Confirmation, Blood” replaced by PETHC – “Phosphatidylethanol, Blood”	Jump to update
08/25/2026	Inactivated/Replace Test	UGABA – “Gabapentin, Urine” replaced by UCGAB – “Clin Urine Gabapentin Confirm”	Jump to update
08/25/2026	Inactivated/Replace Test	UMPDM – “Methylphenidate and Metabolite, Urine” replaced by UCMPD – “Clin Urine Methylphenidate and Ritalinic Acid Confirm”	Jump to update
08/25/2026	Inactivated/Replace Test	UPREG – “Pregabalin, Urine” replaced by UCPGL – “Clin Urine Pregabalin Confirm”	Jump to update

PN04C – “Drug Screen, Pain Management Panel 4”

Effective Date 07/28/2026

Update Type New Test

Test Update View Test Update ›

Test Details

Mnemonic

PN04C

Ordering Code

3000394

CPT-4 Codes(s)

80307, 80355 (G0480), 80366 (G0480), 80360 (G0480)

Turnaround Time

2 - 6 days

Performed

Monday - Friday

Legacy Code

PN04C

Example Report

Download

Specimen Information

Collect

Random urine

Specimen Preparation

30.0 mL urine in a screw capped plastic urine container.
Newborn minimum requires 2.5 mL urine for the initial test and 0.5-5.0 mL for positive confirmations.

Minimum Volume

15.0 mL

Transport Temperature

Refrigerated

Rejection Criteria

Urine catheter cup (with needle). Samples received at room temperature.

Stability

Room temperature: Unacceptable
Refrigerated: 14 days
Frozen: 30 days

Methodology

Enzyme Immunoassay; Gas Chromatography/Mass Spectrometry; Liquid Chromatography/Mass Spectrometry/Mass Spectrometry

Reference Range

See report

Performing Laboratory

Warde Medical Laboratory

New York DOH Approval Status

Test Name	Ordering Code	Result Code	Component Name	LOINC Code	AOE Prompt
3000394	Drug Screen, Pain Management Panel 4
		1846080	Amphetamine Screen	3349-8	No
		1846090	Confirm for Amphetamine	16234-7	No
		1846100	Confirm for Methamphetamine	16235-4	No
		1846110	Confirm for MDA	20545-0	No
		1846120	Confirm for MDMA	18358-2	No
		1846130	Confirm for MDEA	45143-5	No
		1848900	Barbiturate Screen	3377-9	No
		1848905	Confirm for Amobarbital	16239-6	No
		1848910	Confirm for Butabarbital	16236-2	No
		1848915	Confirm for Butalbital	16237-0	No
		1848920	Confirm for Pentobarbital	16240-4	No
		1848950	Confirm for Phenobarbital	16241-2	No
		1848955	Confirm for Secobarbital	16238-8	No
		1848960	Benzodiazepine Screen	3390-2	No
		1848965	Confirm for Alprazolam	59615-5	No
		1848970	Confirm for Clonazepam	16229-7	No
		1848975	Confirm for Flurazepam	16231-3	No
		1848980	Confirm for Lorazepam	17088-6	No
		1848985	Confirm for Nordiazepam	16228-9	No
		1848990	Confirm for Oxazepam	16201-6	No
		1848995	Confirm for Temazepam	20559-1	No
		1849250	Buprenorphine Screen	3414-0	No
		1849260	Confirm for Buprenorphine	49752-9	No
		1849270	Confirm for Norbuprenorphine	49751-1	No
		1847060	Cocaine Screen	3393-6	No
		1847070	Confirm for Cocaine	16226-3	No
		1849005	Ethanol Screen	5644-0	No
		1849010	Confirm for Ethanol	34180-0	No
		3000966	Ethyl Glucuronide Screen	79239-0	No
		3000967	Ethyl Sulfate	60676-4	No
		3000968	Ethyl Glucuronide	45324-1	No
		1828410	Fentanyl	58379-9	No
		1839220	Confirm for Fentanyl	58381-5	No
		1839240	Confirm for Norfentanyl	58383-1	No
		3000464	Gabapentin	59680-9	No
		1828510	Meperidine	58385-6	No
		1838120	Confirm for Meperidine	16253-7	No
		1838140	Confirm for Normeperidine	58389-8	No
		1849280	Methadone Screen	3773-9	No
		1849290	Confirm for Methadone	16246-1	No
		1849285	Confirm for EDDP	58429-2	No
		3000466	Methylphenidate	3809-1	No
		3000467	Ritalinic Acid	33507-5	No
		1847480	Opiate Screen	3879-4	No
		1847510	Confirm For Morphine	16251-1	No
		1847520	Confirm For Codeine	16250-3	No
		1848530	Confirm For Hydrocodone	16252-9	No
		1847540	Confirm For Hydromorphone	16998-7	No
		1847550	Confirm For Oxycodone	16249-5	No
		1847560	Confirm For Oxymorphone	17395-5	No
		1847810	Phencyclidine Screen	3936-2	No
		1847820	Confirm for Phencyclidine	3937-0	No
		3000468	Pregabalin	105953-4	No
		1849310	Propoxyphene Screen	19141-1	No
		1849320	Confirm for Propoxyphene	16242-0	No
		1848020	THC Screen	3427-2	No
		1848030	Confirm for THC	20521-1	No
		1848040	THC/CR Ratio	13478-3	No
		1837210	Tramadol	19710-3	No
		1823520	Confirm for Tramadol	20561-7	No
		1823540	Confirm for O-desmethyltramadol	86453-8	No
		1849330	Creatinine	2161-8	No
		1849340	Adulterant	59061-2	No
		3000969	See Below		No

PETCB – “Phosphatidylethanol Confirmation, Blood” replaced by PETHC – “Phosphatidylethanol, Blood”

Effective Date 08/25/2026

Update Type Inactivated/Replace Test

Test Update View Test Update ›

Inactivated Test Details

Mnemonic

PETCB

Ordering Code

3800363

CPT-4 Codes(s)

80321 (G0480)

Replacement Test Details

Mnemonic

PETHC

Ordering Code

3000971

CPT-4 Codes(s)

80321 (G0480)

Turnaround Time

4 - 6 days

Performed

Tuesday, Thursday

Legacy Code

PETHC

Example Report

Download

Specimen Information

Collect

Lavender EDTA

Specimen Preparation

Send 1.0 mL whole blood in the original tube. Do not aliquot. Do not centrifuge. Do not use alcohol to clean arm. Use alternatives such as Betadine to cleanse arm before collecting any specimen.

Minimum Volume

0.5 mL

Transport Temperature

Refrigerated

Rejection Criteria

Gross lipemia, Gross icterus, Serum separator tube (SST), Red top, not in original collection tube

Stability

Room temperature: Unacceptable
Refrigerated: 14 days
Frozen: 28 days

Methodology

Liquid Chromatography - Tandem Mass Spectrometry

Reference Range

Negative (<10 ng/mL)

Performing Laboratory

Warde Medical Laboratory

New York DOH Approval Status

Test Name	Ordering Code	Result Code	Component Name	LOINC Code	AOE Prompt
Phosphatidylethanol, Blood	3000971
		3000972	POPETH (16:0/18:1)	97607-6	No
		3000973	PLPETH (16:0/18:2)	97606-8	No

UGABA – “Gabapentin, Urine” replaced by UCGAB – “Clin Urine Gabapentin Confirm”

Effective Date 08/25/2026

Update Type Inactivated/Replace Test

Test Update View Test Update ›

Inactivated Test Details

Mnemonic

UGABA

Ordering Code

3515240

CPT-4 Codes(s)

80355 (G0480)

Replacement Test Details

Mnemonic

UCGAB

Ordering Code

3000457

CPT-4 Codes(s)

80355 (G0480)

Turnaround Time

2 - 6 days

Performed

Monday - Friday

Legacy Code

UCGAB

Example Report

Download

Specimen Information

This test is for clinical use only and not intended for employment related testing. See Interface Map for complete list of analytes included.

Quantitative confirmation.
This test is designed to detect gabapentin.
False negative results may occur if drugs are present below the tests limit of detection.
Potential ordering options
- Pain confirmation panel that includes gabapentin, PN04C

Collect

Random urine

Specimen Preparation

10.0 mL urine in a screw capped plastic urine container.

Minimum Volume

3.0 mL

Transport Temperature

Refrigerated

Rejection Criteria

Urine catheter cup (with needle)

Stability

Room temperature: 48 hours
Refrigerated: 14 days
Frozen: 30 days

Methodology

Liquid Chromatography - Tandem Mass Spectrometry

Reference Range

Decision Level
Gabapentin: 0.5 µg/mL

Performing Laboratory

Warde Medical Laboratory

New York DOH Approval Status

Test Name	Ordering Code	Result Code	Component Name	LOINC Code	AOE Prompt
Clin Urine Gabapentin Confirm	3000457
		3000464	Gabapentin	59680-9	No
		3000949	Creatinine	2161-8	No
		3000951	Adulterant	58715-4	No

UMPDM – “Methylphenidate and Metabolite, Urine” replaced by UCMPD – “Clin Urine Methylphenidate and Ritalinic Acid Confirm”

Effective Date 08/25/2026

Update Type Inactivated/Replace Test

Test Update View Test Update ›

Inactivated Test Details

Mnemonic

UMPDM

Ordering Code

3300320

CPT-4 Codes(s)

80360 (G0480)

Replacement Test Details

Mnemonic

UCMPD

Ordering Code

3000459

CPT-4 Codes(s)

80360 (G0480)

Turnaround Time

2 - 6 days

Performed

Monday - Friday

Legacy Code

UCMPD

Example Report

Download

Specimen Information

This test is for clinical use only and not intended for employment related testing. See Interface Map for complete list of analytes included.

Quantitative confirmation.
This test is designed to detect methylphenidate and ritalinic acid.
False negative results may occur if drugs are present below the tests limit of detection.
Potential ordering options

Pain confirmation panel that includes methylphenidate and metabolite, PN04C

Collect

Random urine

Specimen Preparation

10.0 mL urine in a screw capped plastic urine container.

Minimum Volume

3.0 mL

Transport Temperature

Refrigerated

Rejection Criteria

Urine catheter cup (with needle). Samples received at room temperature.

Stability

Room temperature: Unacceptable
Refrigerated: 14 days
Frozen: 30 days

Methodology

Liquid Chromatography - Tandem Mass Spectrometry

Reference Range

Decision Level
Methylphenidate: 50 ng/mL
Ritalinic Acid: 50 ng/mL

Performing Laboratory

Warde Medical Laboratory

New York DOH Approval Status

Test Name	Ordering Code	Result Code	Component Name	LOINC Code	AOE Prompt
Clin Urine Methylphenidate and Ritalinic Acid Confirm	3000459
		3000466	Methylphenidate	3809-1	No
		3000467	Ritalinic Acid		No
		3000954	Creatinine	2161-8	No
		3000956	Adulterant	58714-7	No

UPREG – “Pregabalin, Urine” replaced by UCPGL – “Clin Urine Pregabalin Confirm”

Effective Date 08/25/2026

Update Type Inactivated/Replace Test

Test Update View Test Update ›

Inactivated Test Details

Mnemonic

UPREG

Ordering Code

3302220

CPT-4 Codes(s)

80366 (G0480)

Replacement Test Details

Mnemonic

UCPGL

Ordering Code

3000458

CPT-4 Codes(s)

80366 (G0480)

Turnaround Time

2 - 6 days

Performed

Monday - Friday

Legacy Code

UCPGL

Example Report

Download

Specimen Information

This test is for clinical use only and not intended for employment related testing. See Interface Map for complete list of analytes included.

Quantitative confirmation.
This test is designed to detect pregabalin.
False negative results may occur if drugs are present below the tests limit of detection.
Potential ordering options

Pain confirmation panel that includes pregabalin, PN04C

Collect

Random urine

Specimen Preparation

10.0 mL urine in a screw capped plastic urine container.

Minimum Volume

3.0 mL

Transport Temperature

Refrigerated

Rejection Criteria

Urine catheter cup (with needle)

Stability

Room temperature: 48 hours
Refrigerated: 14 days
Frozen: 30 days

Methodology

Liquid Chromatography - Tandem Mass Spectrometry

Reference Range

Decision Level
Pregabalin: 0.5 µg/mL

Performing Laboratory

Warde Medical Laboratory

New York DOH Approval Status

Test Name	Ordering Code	Result Code	Component Name	LOINC Code	AOE Prompt
Clin Urine Pregabalin Confirm	3000458
		3000468	Pregabalin	105953-4	No
		3000952	Creatinine	2161-8	No
		3000953	Adulterant	58714-7	No

July 2026 WML Test Directory Toxicology Update (Correction)

Announcement

Update Summary

PN04C – “Drug Screen, Pain Management Panel 4”

Test Details

Mnemonic

Ordering Code

CPT-4 Codes(s)

Specimen Information

Collect

Specimen Preparation

Minimum Volume

Transport Temperature

Rejection Criteria

Stability

Methodology

Reference Range

Performing Laboratory

New York DOH Approval Status

Interface Map for PN04C

PETCB – “Phosphatidylethanol Confirmation, Blood” replaced by PETHC – “Phosphatidylethanol, Blood”

Inactivated Test Details

Mnemonic

Ordering Code

CPT-4 Codes(s)

Replacement Test Details

Mnemonic

Ordering Code

CPT-4 Codes(s)

Specimen Information

Collect

Specimen Preparation

Minimum Volume

Transport Temperature

Rejection Criteria

Stability

Methodology

Reference Range

Performing Laboratory

New York DOH Approval Status

Interface Map for PETHC

UGABA – “Gabapentin, Urine” replaced by UCGAB – “Clin Urine Gabapentin Confirm”

Inactivated Test Details

Mnemonic

Ordering Code

CPT-4 Codes(s)

Replacement Test Details

Mnemonic

Ordering Code

CPT-4 Codes(s)

Specimen Information

Collect

Specimen Preparation

Minimum Volume

Transport Temperature

Rejection Criteria

Stability

Methodology

Reference Range

Performing Laboratory

New York DOH Approval Status

Interface Map for UCGAB

UMPDM – “Methylphenidate and Metabolite, Urine” replaced by UCMPD – “Clin Urine Methylphenidate and Ritalinic Acid Confirm”

Inactivated Test Details

Mnemonic

Ordering Code

CPT-4 Codes(s)

Replacement Test Details

Mnemonic

Ordering Code

CPT-4 Codes(s)

Specimen Information

Collect

Specimen Preparation

Minimum Volume

Transport Temperature

Rejection Criteria

Stability

Methodology

Reference Range